Scroll To Top
Search by Speciality

14TH ANNUAL WORLD CONGRESS ON INSULIN RESISTANCE, DIABETES & CARDIOVASCULAR DISEASE

Hilton Universal City Hotel | Los angeles, USA
From 355 to 695 USD
Event Preview
EXPIRED
This event
is Finished
Title: 14TH ANNUAL WORLD CONGRESS ON INSULIN RESISTANCE, DIABETES & CARDIOVASCULAR DISEASE
Specialty: Endocrinology
Dates: From Dec, 1, 2016 to Dec, 3, 2016
Location: Los angeles, USA
Type: Congress
Registration Cost: From 355 to 695 USD
Event Tools
  • Add to Favorites
  • Claim this event
Add to my Calendar
  • Scientific Programm
  • Online registration
  • Exhibition floorplans
  • Sponsorship &
    Exhibition consensus
  • Virtual Booths
Dec
Weather Info (monthly averages) Max Temperature: C / F Min Temperature: C / F The above data in our Weather Info table are temperature predictions for the date of the medical event for LOS ANGELES, Usa.
General Info
Event Venue:

Hilton Universal City Hotel

LOS ANGELES, USA Visit the Venue to read more
Currency:
USD
Concerned Audience:
  • Medical_Professionals
  • Medical_students
  • Nurses
Event Overview
Welcome message:

The World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC), now in its 14th year, is a unique and exciting multidisciplinary program. The Congress is the premiere global meeting dedicated to diabetes, obesity, metabolism, and energy balance, linking research to clinical practice, and highlighting our theme: Exploring New Frontiers in Metabolism — Tomorrow’s Clinical Science Today.


For more than a decade, the World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC) has brought researchers, physicians, and other clinicians & healthcare professionals together for a distinctive international program that bridges bench to bedside. WCIRDC offers attendees a unique experience where they may interact with the distinguished global faculty to experience a program which promotes a new understanding of metabolic diseases, facilitates the development of future therapeutic modalities, and implements the management of obesity and diabetes by focusing on lifestyle and beyond and by evaluating contemporary medications, devices, and surgeries used in preventing CVD and other complications.


Since Dr. Gerald Reaven’s pioneering work crystallized the relationship between insulin resistance (IR), diabetes, and cardiovascular disease (CVD), the Congress’ focus has expanded to evaluating both clinical and basic science aspects of diabetes, obesity, and CVD, focusing beyond insulin resistance and hyperinsulinemia on obesity, the fat cell, incretins, the kidney and energy metabolism, cardiovascular complications, and cancer. The Congress further addresses lipid abnormalities, hypertension, and hypercoagulation. The goal is to understand the pathophysiology and the epidemic of obesity and diabetes, and to develop appropriate comprehensive clinical management plans.


Highlights of this year’s program:


Lifetime Achievement Award Presentation and Keynote Address: Gerald Reaven, MD.

Distinguished Leader in Insulin Resistance Award and Lecture: Arun J. Sanyal, MD.

Special Symposia: State of the Art of Incretin Therapy: Daniel Drucker, MD, and Jens J. Holst, PhD

The Scientific Approach to Personalized Medicine in the Management of Diabetes: Focus on Nutrition, Exercise and Individualized Pharmacotherapy;

Medications in the Pipeline: Obesity, Diabetes, and Other Metabolic Disorders.

Other highlights: Congestive Heart Failure, Lipids and Atherosclerosis, and Thrombosis.

Management of Obesity- pharmacological agents, Endoscopic Therapy and bariatric surgery.

For primary care clinicians, the Congress will feature a series of workshops and “meet the expert” panels addressing the clinical management of kidney disease, diabetes, obesity, lipids, the high risk CVD patients and more. To make basic and clinical research topics in metabolism, vascular biology, obesity and diabetes relevant to clinical medicine, there will be commentaries on its clinical implications by recognized clinical experts. The strength and advantage of the Congress is through its intimate setting that promotes personal and direct contact between participants and the distinguished faculty.


The Congress attracts state-of-the-art abstracts from around the globe. These abstracts will be published in Endocrine Practice, the official journal of the American Association of Clinical Endocrinologists (AACE). Typically, articles about the meeting are published in several medical journals, such as Endocrine Practice, Metabolism, The Journal of Diabetes, and Diabetes Care.

Registration Needs updating Register Now
Currency:

USD

Registration Cost
Type
Early Registration

2016-09-07
Late Registration From: 2016-09-08 To: 0--
On site Registration
Attendee
495
650
695
Member
395
495
559
Student
355
390
415

Group Registrations:

Group registrations not allowed

Accompanying Persons:

Accompanying persons not allowed

Registration Documents:
Letter of invitation:
We don’t provide letter of invitation
Letter of confirmation:
We don’t provide Letter of Confirmation
Proof of professional / educational status:
We don’t need Proof of professional/educational status
Online Abstract Submission:

We don’t accept Online Abstracts

Accommodation
Accommodation:

Hilton Universal City Hotel


555 Universal Hollywood Drive


Universal City CA 91608

Scientific Content Up to Date
Submission Info

Diabetes, obesity, dyslipidemia, hypertension, cardiovascular disease, malignancy, liver disease, renal disease, gonadal dysfunction, sleep disorders such as obstructive sleep apnea


Basic science:


Mechanisms of insulin resistance, inflammation, endothelial and vascular dysfunction, metabolic dysfunction of centers such as the beta cell, adipocyte, gut, and brain


Guidelines:


Abstracts should address either clinical or basic science aspects of insulin resistance, in fields such as diabetes, obesity, and cardiovascular disease.  Investigations of overall pathophysiology and/or effects on key metabolic centers such as the beta cell, adipocyte, gut, and brain would be of interest, as would be studies of inflammation and of endothelial or other vascular dysfunction. Clinical topics may include any aspect of insulin resistance in childhood, adolescence and/or adulthood in relationship to the causation and/or natural history of obesity, diabetes, hypertension, dyslipidemia, cardiovascular disease, renal disease, gonadal dysfunction (including both PCOS and male hypogonadism), gestational diabetes, other endocrine abnormality, liver disease (NAFLD), malignancy, and sleep disorders such as obstructive sleep apnea.


The interests of the Congress include multi-hormonal aspects of obesity, incretins and other gut hormonal contributions to energy balance, and circadian rhythm as it relates to these metabolic mechanisms. Basic science studies should include those with specific relationship to insulin action and its regulation at the cellular, organ, or whole body level.


To demonstrate their conformity to this guideline, authors are encouraged to include a brief clarification of the relationship of their topic to insulin resistance and/or to the above metabolic processes.


In addition:


Scientific materials presented at the 14th Annual World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease must not have been published or presented prior to November 1st, 2016, other than in abstract form.

All abstracts must be submitted electronically: http://wcir.org/2015-congress-info/abstracts/send-abstract/  on a Microsoft Word document of no more than 250 words. Graphs are allowed not to exceed 8.5”  X 11” word document   (No PDF documents will be accepted, or any submissions by fax or mail.)

All materials must arrive on or before the abstract deadline noted above.

Notification for acceptance will be e-mailed as soon as the committee accepts the abstract.

Authorship on multiple abstracts is permitted.

All submitted materials will be graded by the scientific planning committee, The International Committee for Insulin Resistance.

Abstracts may be submitted for poster presentation. If selected for poster presentation, the author is required to register for the Congress and to be present during the poster sessions. Awards will be given for the highest-ranking abstracts. The award levels are: Gold, Silver, Bronze, and honorable mention. The authors of the winning abstracts will orally present their research findings during the Plenary Sessions in a ten minute presentation, to be followed by a five minute period of discussion.

If selected for oral presentation, an author is required to register for the Congress and to be prepared for the oral presentation with a PowerPoint presentation.  Abstracts must be accompanied by a statement from the authors agreeing that, if chosen, they will prepare a poster presentation, and that, if awarded a high ranking, they will prepare an oral presentation.

Abstracts will be published in: Endocrine Practice.Editor-in-Chief – Derek Leroith, MD, PhD “Endocrine Practice is a peer-reviewed journal published six times a year, and is the official journal of the American Association of Clinical Endocrinologists (AACE). The first issue of Endocrine Practice was published in 1995. The primary mission of Endocrine Practice is to enhance the health care of patients with endocrine diseases through continuing education of practicing endocrinologists.”

 

Sponsors Exhibitors
General Info

Kaley Diep , Executive Assistant , Metabolic Endocrine Education Foundation (MEEF)

Phone: 818-342-1889

Fax: 818-342-1538

Email: admin@wcir.org

Contact
Organising Agency

Kaley Diep , Executive Assistant , Metabolic Endocrine Education Foundation (MEEF)

Phone: 818-342-1889

Fax: 818-342-1538

Email: admin@wcir.org

Official Event Webpage
Event map
Revelant Events